New drug shows promise for vitiligo in early trial

NCT ID NCT04338581

First seen Nov 17, 2025 · Last updated May 06, 2026 · Updated 25 times

Summary

This study tested a drug called AMG 714 in 60 adults with vitiligo, a condition that causes white patches on the skin. The goal was to see if the drug could help bring back skin color on the face after 24 weeks of treatment. Participants received either the drug or a placebo, and the results have been completed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VITILIGO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Henry Ford Health System

    Detroit, Michigan, 48202, United States

  • Northwell Health

    Lake Success, New York, 11042, United States

  • Tufts Medical Center: Department of Dermatology

    Boston, Massachusetts, 02111, United States

  • University of California Davis Health System: Department of Dermatology

    Sacramento, California, 95816, United States

  • University of California, Irvine: Department of Dermatology

    Irvine, California, 92697, United States

  • University of Massachusetts Medical School

    Worcester, Massachusetts, 01605, United States

  • Yale University School of Medicine: Department of Dermatology

    New Haven, Connecticut, 06520, United States

Conditions

Explore the condition pages connected to this study.